France’s Grand Ouest region, working together to exit the health crisis

Latest Posts

Valneva and Pfizer report further positive phase 2 data for Lyme disease vaccine candidate

4 February 2022

Dose selection complete for planned Phase 3 trial, expected to be initiated in 3Q2022 Sub-analysis compared the immunogenicity of VLA15... View Article

Transnational EU-project CE4BIG on Cluster Management Excellence and SME support draws to a close

1 February 2022

In the framework of CE4BIG (Cluster Excellence for Business, Innovation and Growth in the health sector), supported bythe EU COSME... View Article

Valneva announces initiation of adolescent phase 3 trial for its single-shot chikungunya vaccine candidate

CEPI-funded trial intended to support potential label expansion in this age group Valneva, a specialty vaccine company, today announced the... View Article

« Previous 1 … 26 27 28 29 30 … 160 Next »